跳至主要内容
临床试验/PACTR202203874034949
PACTR202203874034949尚未招募3 期

Polyphenol-Rich Cocoa Powder As Adjuvant Therapy In Patients With Covid-19

Ghana Cocoa Board0 个研究点目标入组 126 人开始时间: 2022年2月4日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
All

入选标准

  • . Confirmed COVID-19 positivity at admission
  • . Ability to tolerate oral medication and oral food intake

排除标准

  • Patients who are unable to swallow/receive oral medication
  • Patients requiring ICU care on screening
  • Pregnant or lactating COVID-19 patients - based on their declaration and pregnancy test results when required.
  • Self-reported known allergies or intolerance to natural cocoa
  • Inability or unwillingness to be followed up for the trial period

研究者

发起方
Ghana Cocoa Board

相似试验